I've always approached new medications with caution, concerned about potential side effects. That hesitation is why it took me several weeks to finally try Pulmozyme for the first time.

The REsearch Study to Advance the CF THerapeutics Pipeline for People without Modulators (REACH) is a study for all people with cystic fibrosis who do not take CFTR modulators, regardless of their ...